Specialized consulting, interim management M&A due diligence for the pharmaceutical and chemical industries.
Strategic Growth for Pharma & Biotech
Janssen Pharma Consult GmbH is located in Duggingen, Switzerland and was founded in November 2025. Janssen Pharma Consult GmbH provides specialized business consulting, interim management, and M&A due diligence for the pharmaceutical/chemical industries. Led by Maurits Janssen, the company focuses on commercial strategies, investment planning, and expert advisory.

About Me
Maurits Janssen is a Dutch Life Science executive with nearly three decades of experience in commercial strategy, business development, and M&A across the pharmaceutical and biotech industry. Holding a PhD in Organic Chemistry from Utrecht University, he has held senior roles at companies including Lonza, Siegfried, and Sigma-Aldrich — most recently serving as Head of Strategy for Lonza's Small Molecules Division, where he doubled the business through targeted investment programs in HPAPI and ADC technologies.
In November 2025, Maurits founded Janssen Pharma Consult GmbH to independently support companies in achieving sustainable growth through commercial, organic, and inorganic (M&A) solutions.
- 25+ years of commercial and strategic leadership in pharmaceutical, life sciences, and high-tech industries. Strong CDMO industrial track record spanning small molecules through biologics and ADC.
- Proven in driving strategic growth through organic (capital investment & innovation) and inorganic (M&A) programs — more than doubling the business.
- Expert in translating complex technologies into scalable, de-risked business models. Trusted negotiator and commercial strategist with global pharma clients.
- Developed various team members through different career stages, including organizational restructuring. Team player in international and multicultural environments.
Our Vision & Values
Supporting customers in Pharma and Biotech to achieve sustainable growth through temporary or longer-term consulting assignments, acting as partner to drive their strategy development and implementation to align with long-term market trends in today's highly competitive market.
Integrity
Challenge the Status Quo
Collaboration & Partnership
Sustainable and Profitable Growth
Services
Whether you are an emerging Biotech or Pharma company, a drug delivery firm, a CRO or a CDMO, or a Private Equity Institution — I am specialized in strategic growth and support companies in realizing sustainable revenue growth.

Commercial Leadership & Negotiations

Idea Generation, Investment Concepts, M&A
Assessments
What Clients Say
Alberto Kravina - Former colleague at Lonza
"Thanks a lot for the great time we have spent together. I always came out of meetings wiser when you were in the room."
Nick Fortin, CEO — CODIS (Global CDMO, Spray-Drying & Particle Engineering)
"Janssen Pharma Consult and CODIS found each other during both our beginning of a new chapter and working with Maurits was a great asset for our journey to complete our global presence and service offerings. I wholeheartedly recommend Maurits for any mission requiring strategic vision, decisive execution, and collaborative leadership."
Ross Gale, Vice President — International Process Plants
"Maurits, you are an asset to the strategic development and execution of any project. 10/10 would recommend!"
Han Dragt, Chairman — CPhP / former business partner at Solvay Pharmaceuticals/Abbott
"Great comprehensive summary Maurits. It is a true value you offer to pharma and biotech companies. I remember very well the days we have been working together where I had the commercial lead at one of the first virtual pharmaceutical companies. It was a very good cooperation with you, I still cherish those days."
Anthony Macci, President & Founder — The Macci Group
"You certainly will add value with your knowledge and insight. I wish you continued success."



